A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

PURPOSE: As a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients with coronary heart disease (CHD) who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qiang, Zhao, Ying, Wang, Haiyan, Zhao, Jiayu, Wang, Xun, Shi, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403046/
https://www.ncbi.nlm.nih.gov/pubmed/36035940
http://dx.doi.org/10.3389/fcvm.2022.857922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403046/
https://www.ncbi.nlm.nih.gov/pubmed/36035940
http://dx.doi.org/10.3389/fcvm.2022.857922

Ejemplares similares